Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-03-13 @ 5:34 PM
Study NCT ID:
NCT00620659
Status:
TERMINATED
Last Update Posted:
2015-05-13
First Post:
2008-01-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2009-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-02
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-10
First Submit QC Date:
None
Study First Post Date:
2008-02-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-10-13
Results First Submit QC Date:
None
Results First Post Date:
2011-02-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-04-27
Last Update Post Date:
2015-05-13
Last Update Post Date Type:
ESTIMATED